Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 589 of 1,261
  1. US 9855312

    GHRH agonists for the treatment of ischemic disorders

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  2. US 9855305

    Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors

    Compass Therapeutics LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  3. US 9855298

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  4. US 9855303

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  5. US 9855252

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  6. US 9855278

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  7. US 9855274

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  8. US 9855279

    Methods of treating oral mucositis

    Galera Labs, LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  9. US 9855249

    Isoxazole compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  10. US 9855241

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  11. US 9856233

    Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

    The Board of Regents of the University of Texas System · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  12. US 9855226

    d-methadone for the treatment of psychiatric symptoms

    Relmada Therapeutics, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  13. US 9855196

    Dental curable composition and dental flowable composite resin

    KURARAY NORITAKE DENTAL INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  14. US 9855195

    Dental curable composition

    JGC Catalysts and Chemicals Ltd. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  15. US 2017369501

    KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS

    4SC AG [DE] · Granted Dec 28, 2017 · Expires Dec 23, 2037

    granted
  16. US 9850542

    Gene signature to predict homologous recombination (HR) deficient cancer

    The Board of Regents of the University of Texas System · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  17. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  18. US 9849167

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  19. US 9849100

    Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities

    KalVista Pharmaceuticals Limited · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  20. US 9850488

    Complement component C5 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  21. US 9850277

    Therapeutically active compositions and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  22. US 9850323

    High concentration chitosan-nucleic acid polyplex compositions

    ENGENE, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  23. US 9850300

    Compositions and methods relating to inhibiting cancer cell growth and/or proliferation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  24. US 9850313

    Cancer biomarkers and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.